Diabetes and the Risk of Long-term Post-COVID Symptoms

Area of Science:

• Infectious Diseases
• Endocrinology
• Pulmonology

Background:

• Long-term post-coronavirus disease (COVID) symptoms are a significant concern for recovered patients.
• The impact of pre-existing diabetes on the development of these long-term symptoms remains an area of investigation.

Purpose of the Study:

• To investigate the association between diabetes and the presence of long-term post-COVID symptoms in patients who recovered from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
• To determine if diabetes is a risk factor for experiencing persistent post-COVID symptoms.

Main Methods:

• A case-control study was conducted with individuals hospitalized during the first pandemic wave.
• Case subjects had a prior diabetes diagnosis, while control subjects did not; both groups recovered from COVID-19.
• Data collected included hospitalization records, telephone interviews assessing post-COVID symptoms, anxiety, depression, and sleep quality.

Main Results:

• The study assessed 145 patients with diabetes and 144 controls approximately 7 months post-discharge.
• No significant differences were found in the number or type of post-COVID symptoms (e.g., fatigue, dyspnea) between diabetic and non-diabetic groups.
• Limitations in daily living activities were also similar between the groups.

Conclusions:

• Diabetes was not identified as a risk factor for developing long-term post-COVID symptoms.
• Pre-existing diabetes does not appear to influence the likelihood or severity of persistent symptoms after SARS-CoV-2 infection.